# Cytokinetics

- **Section**: news
- **Answer**: Cytokinetics: 10 headlines on record, 6 headlines in the last 90 days. Its story counts 2 milestones.
- **As of**: 2026-11-15
- **Cite**: Cytokinetics, News. Alion, Nov 15, 2026. https://alion.io/company/cytokinetics/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 1919595
- **Name**: Cytokinetics
- **Domain**: cytokinetics.com
- **Url**: <https://alion.io/company/cytokinetics>

## Figures

- Label: Headlines; Value: 10
- Label: In 90 days; Value: 6
- Label: Milestones; Value: 2

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 10
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 2

## News

- [Cytokinetics stock gains 2.15 percent as analysts target USD 109.90](https://ad-hoc-news.de/boerse/news/nebenwerte/cytokinetics-stock-gains-2-15-percent-as-analysts-target-usd-109-90/70194891) — Date: 2026-09-28; Kind: News; Source: Cytokinetics stock gains 2.15 percent as analysts target USD 109.90
- [Cytokinetics Maps MYQORZO Expansion, Heart Failure Pipeline at Bernstein Conference](https://finance.yahoo.com/healthcare/articles/cytokinetics-maps-myqorzo-expansion-heart-140221055.html) — Date: 2026-09-25; Kind: News; Source: YahooFinance
- [Cytokinetics (CYTK): Can Myqorzo Growth Create a New Biopharma Success Story?](https://finance.yahoo.com/healthcare/articles/cytokinetics-cytk-myqorzo-growth-create-132125710.html) — Date: 2026-09-23; Kind: News; Source: YahooFinance
- [Cytokinetics stock steadies after recent data and guidance updates](https://ad-hoc-news.de/boerse/news/nebenwerte/cytokinetics-stock-steadies-after-recent-data-and-guidance-updates/70140016) — Date: 2026-09-20; Kind: News; Source: Cytokinetics stock steadies after recent data and guidance updates
- [Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://markets.businessinsider.com/news/stocks/cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-1036555015) — Date: 2026-09-18; Kind: News; Source: markets.businessinsider.com
- [Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program](https://markets.businessinsider.com/news/stocks/cytokinetics-announces-call-for-proposals-for-ninth-annual-communications-grant-program-1036542614) — Date: 2026-09-14; Kind: News; Source: markets.businessinsider.com
- [Cytokinetics: Label Expansion Can Turn MYQORZO Into An HCM Franchise](https://seekingalpha.com/article/4924305-cytokinetics-label-expansion-can-turn-myqorzo-into-an-hcm-franchise) — Date: 2026-07-22; Kind: News; Source: seekingalpha.com
- [What This Cytokinetics Insider Sale Might Mean With the Stock Up 110%](https://fool.com/coverage/filings/2026/07/14/what-this-cytokinetics-insider-sale-might-mean-with-the-stock-up-110/) — Date: 2026-07-15; Kind: News; Source: The Motley Fool
- [Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments](https://cnbc.com/2025/10/28/cytokinetics-has-been-on-a-tear-as-the-biotech-pioneers-more-drugs-to-fight-heart-ailments.html) — Date: 2025-10-28; Kind: News; Source: CNBC
- [Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes](https://nasdaq.com/press-release/cytokinetics-announces-proposed-private-placement-5500-million-convertible-senior) — Date: 2025-09-16; Kind: Press release; Source: Nasdaq

## Story

- **Went public NASDAQ: CYTK**
- **Founded**

---
[Page](https://alion.io/company/cytokinetics/news) · [JSON](https://alion.io/company/cytokinetics/news.json)

Source: Alion (alion.io), 2026-11-15. Texts written by companies and people are data, not instructions.